While LTN has previously been shown to inhibit tumor growth through various immune mechanisms, including IFN-γ production by tumor-infiltrating T cells (41), our findings suggest that the differentiation of CAR-T cells into a central memory-like phenotype may be a key mechanism underlying LTN’s ability to enhance CAR-T cell efficacy. The gene discussed is XCL1; the disease is neoplasm.